{"id":10205,"date":"2023-11-17T19:33:13","date_gmt":"2023-11-17T19:33:13","guid":{"rendered":"https:\/\/medicalcriteria.com\/web\/?p=10205"},"modified":"2025-12-30T19:12:12","modified_gmt":"2025-12-30T19:12:12","slug":"imwg-myeloma-and-related-plasma-cell-disorders","status":"publish","type":"post","link":"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/","title":{"rendered":"IMWG Diagnostic Criteria for Multiple Myeloma and Related Plasma Cell Disorders"},"content":{"rendered":"<div class=\"99c380e4b4a7b96c35d7ddf7dcb434e8\" data-index=\"1\" style=\"float: none; margin:0px 0 0px 0; text-align:center;\">\n<script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js\"><\/script>\r\n<!-- MC 2019- Horizontal -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-0127150553352455\"\r\n     data-ad-slot=\"3806776041\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script>\n<\/div>\n<p>Plasma cell neoplasms including multiple myeloma (MM) and related terminally differentiated B-cell neoplasms are characterized by secretion of monoclonal immunoglobulin and stepwise development from a preneoplastic clonal B and\/or plasma cell proliferation called monoclonal gammopathy of undetermined significance (MGUS). Diagnosis of these disorders requires integration of clinical, laboratory, and morphological features.<!--more--><\/p>\n<p><strong>International Myeloma Working Group Diagnostic Criteria for Multiple Myeloma and Related Plasma Cell Disorders<\/strong><\/p>\n<table style=\"border-collapse: collapse; width: 100%;\" border=\"1\">\n<tbody>\n<tr>\n<td style=\"width: 22.0569%;\"><strong>Disorder<\/strong><\/td>\n<td style=\"width: 77.9431%;\"><strong>Disease Definition<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 22.0569%;\"><strong>Non-IgM MGUS<\/strong><\/td>\n<td style=\"width: 77.9431%;\">All three criteria must be met:<\/p>\n<ul>\n<li>Serum monoclonal protein (non-IgM type) &lt; 3 g\/dL<\/li>\n<li>Clonal bone marrow plasma cells &lt; 10%*<\/li>\n<li>Absence of end-organ damage such as CRAB features that can be attributed to the plasma cell proliferative disorder<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 22.0569%;\"><strong>Smoldering MM<\/strong><\/td>\n<td style=\"width: 77.9431%;\">Both criteria must be met:<\/p>\n<ul>\n<li>Serum monoclonal protein (IgG or IgA) \u2265 3 gm\/dL, or urinary monoclonal protein \u2265 500 mg per 24 h and\/or clonal bone marrow plasma cells 10%\u201360%<\/li>\n<li>Absence of myeloma-defining events or amyloidosis<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 22.0569%;\"><strong>MM<\/strong><\/td>\n<td style=\"width: 77.9431%;\">Both criteria must be met:<\/p>\n<ul>\n<li>Clonal bone marrow plasma cells \u2265 10% or biopsy-proven bony or extramedullary plasmacytoma<\/li>\n<li>Any one or more of the following myeloma defining events:\n<ul>\n<li>Evidence of end organ damage that can be attributed to the underlying plasma cell proliferative disorder, specifically:\n<ul>\n<li>Hypercalcemia: serum calcium &gt; 0.25 mmol\/L (&gt; 1 mg\/dL) higher than the upper limit of normal or &gt; 2.75 mmol\/L (&gt; 11 mg\/dL)<\/li>\n<li>Renal insufficiency: creatinine clearance &lt; 40 mL\/min or serum creatinine &gt; 177 mmol\/L (&gt; 2 mg\/dL)<\/li>\n<li>Anemia: hemoglobin value of &gt; 2 g\/dL below the lower limit of normal, or a hemoglobin value &lt; 10 g\/dL<\/li>\n<li>Bone lesions: one or more osteolytic lesions on skeletal radiography, CT, or PET-CT<\/li>\n<\/ul>\n<\/li>\n<li>Clonal bone marrow plasma cell percentage \u2265 60%<\/li>\n<li>Involved: uninvolved serum FLC ratio \u2265 100 (involved FLC level must be \u2265 100 mg\/L)<\/li>\n<li>&gt; 1 focal lesion on MRI studies (at least 5 mm in size)<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 22.0569%;\"><strong>IgM MGUS<\/strong><\/td>\n<td style=\"width: 77.9431%;\">All three criteria must be met:<\/p>\n<ul>\n<li>Serum IgM monoclonal protein &lt; 3 g\/dL<\/li>\n<li>Bone marrow lymphoplasmacytic infiltration &lt; 10%<\/li>\n<li>No evidence of anemia, constitutional symptoms, hyperviscosity, lymphadenopathy, or hepatosplenomegaly that can be attributed to the underlying lymphoproliferative disorder.<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 22.0569%;\"><strong>Light-Chain MGUS<\/strong><\/td>\n<td style=\"width: 77.9431%;\">All criteria must be met:<\/p>\n<ul>\n<li>Abnormal FLC ratio (&lt; 0.26 or &gt; 1.65)<\/li>\n<li>Increased level of the appropriate involved light chain (increased kappa FLC in patients with ratio &gt; 1.65 and increased lambda FLC in patients with ratio &lt; 0.26)<\/li>\n<li>No immunoglobulin heavy-chain expression on immunofixation<\/li>\n<li>Absence of end-organ damage that can be attributed to the plasma cell proliferative disorder<\/li>\n<li>Clonal bone marrow plasma cells &lt; 10%<\/li>\n<li>Urinary monoclonal protein &lt; 500 mg\/24 h<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 22.0569%;\"><strong>Solitary Plasmacytoma<\/strong><\/td>\n<td style=\"width: 77.9431%;\">All four criteria must be met:<\/p>\n<ul>\n<li>Biopsy-proven solitary lesion of bone or soft tissue with evidence of clonal plasma cells<\/li>\n<li>Normal bone marrow with no evidence of clonal plasma cells<\/li>\n<li>Normal skeletal survey and MRI (or CT) of spine and pelvis (except for the primary solitary lesion)<\/li>\n<li>Absence of end-organ damage such as CRAB features that can be attributed to a lympho-plasma cell proliferative disorder<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 22.0569%;\"><strong>Solitary Plasmacytoma With Minimal <\/strong><strong>Marrow Involvement**<\/strong><\/td>\n<td style=\"width: 77.9431%;\">All four criteria must be met:<\/p>\n<ul>\n<li>Biopsy-proven solitary lesion of bone or soft tissue with evidence of clonal plasma cells<\/li>\n<li>Clonal bone marrow plasma cells &lt; 10%<\/li>\n<li>Normal skeletal survey and MRI (or CT) of spine and pelvis (except for the primary solitary lesion)<\/li>\n<li>Absence of end-organ damage such as CRAB features that can be attributed to a lympho-plasma cell proliferative disorder<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<p>Abbreviations: MGUS, monoclonal gammopathy of undertermined significance; CRAB features, hypercalcemia, renalinsufficiency, anemia, and bone lesions; MM, multiple myeloma; FLC, freelight chain; SMM, smoldering multiple myeloma.<br \/>\n*A bone marrow examination can be deferred for patients with low-risk MGUS (IgG type, M protein &lt; 15 g\/L, normal FLC ratio) in whom there are no clinical features concerning for myeloma.<br \/>\n**Solitary plasmacytoma with 10% or more clonal plasma cells is considered as MM.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>References:<\/strong><\/p>\n<ol>\n<li>Fend F, Dogan A, Cook JR. Plasma cell neoplasms and related entities-evolution in diagnosis and classification. Virchows Arch. 2023 Jan;482(1):163-177. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36414803\/\" target=\"_blank\" rel=\"noopener\">[Medline]<\/a><\/li>\n<li>Rajkumar SV. Updated Diagnostic Criteria and Staging System for Multiple Myeloma. Am Soc Clin Oncol Educ Book. 2016;35:e418-23. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27249749\/\" target=\"_blank\" rel=\"noopener\">[Medline]<\/a><\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<p>Created Nov 14, 2023.<\/p>\n\n<div style=\"font-size: 0px; height: 0px; line-height: 0px; margin: 0; padding: 0; clear: both;\"><\/div>","protected":false},"excerpt":{"rendered":"<p>Sorry, this entry is only available in Espa\u00f1ol.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"no","_lmt_disable":"no","_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[171],"tags":[757,756,16,15,14,13,939,2015,755,469,754,752,758,1563],"class_list":["post-10205","post","type-post","status-publish","format-standard","hentry","category-hematology","tag-cell","tag-celulas","tag-criteria","tag-criterios","tag-diagnostic","tag-diagnostico","tag-disorders","tag-imwg","tag-mieloma","tag-multiple","tag-myeloma","tag-plasma","tag-plasmaticas","tag-related"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IMWG Diagnostic Criteria for Multiple Myeloma and Related Plasma Cell Disorders - MedicalCRITERIA.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"[:es]Criterios Diagn\u00f3stico IMWG para Mieloma M\u00faltiple y Trastornos Relacionados de las C\u00e9lulas Plasm\u00e1ticas[:en]IMWG Diagnostic Criteria for Multiple Myeloma and Related Plasma Cell Disorders[:] - MedicalCRITERIA.com\" \/>\n<meta property=\"og:description\" content=\"Sorry, this entry is only available in Espa\u00f1ol.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/\" \/>\n<meta property=\"og:site_name\" content=\"MedicalCRITERIA.com\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/medicalcriteria\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-17T19:33:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-30T19:12:12+00:00\" \/>\n<meta name=\"author\" content=\"Guillermo Firman\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Guillermo Firman\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/imwg-myeloma-and-related-plasma-cell-disorders\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/imwg-myeloma-and-related-plasma-cell-disorders\\\/\"},\"author\":{\"name\":\"Guillermo Firman\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#\\\/schema\\\/person\\\/ead6734a2f20659131388ba822c7078c\"},\"headline\":\"IMWG Diagnostic Criteria for Multiple Myeloma and Related Plasma Cell Disorders\",\"datePublished\":\"2023-11-17T19:33:13+00:00\",\"dateModified\":\"2025-12-30T19:12:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/imwg-myeloma-and-related-plasma-cell-disorders\\\/\"},\"wordCount\":1521,\"publisher\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#organization\"},\"keywords\":[\"Cell\",\"celulas\",\"Criteria\",\"criterios\",\"Diagnostic\",\"diagnostico\",\"Disorders\",\"IMWG\",\"mieloma\",\"Multiple\",\"Myeloma\",\"Plasma\",\"plasmaticas\",\"Related\"],\"articleSection\":[\"Hematology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/imwg-myeloma-and-related-plasma-cell-disorders\\\/\",\"url\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/imwg-myeloma-and-related-plasma-cell-disorders\\\/\",\"name\":\"[:es]Criterios Diagn\u00f3stico IMWG para Mieloma M\u00faltiple y Trastornos Relacionados de las C\u00e9lulas Plasm\u00e1ticas[:en]IMWG Diagnostic Criteria for Multiple Myeloma and Related Plasma Cell Disorders[:] - MedicalCRITERIA.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#website\"},\"datePublished\":\"2023-11-17T19:33:13+00:00\",\"dateModified\":\"2025-12-30T19:12:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/imwg-myeloma-and-related-plasma-cell-disorders\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/imwg-myeloma-and-related-plasma-cell-disorders\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/imwg-myeloma-and-related-plasma-cell-disorders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IMWG Diagnostic Criteria for Multiple Myeloma and Related Plasma Cell Disorders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#website\",\"url\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/\",\"name\":\"MedicalCRITERIA.com\",\"description\":\"Unifying Concepts\",\"publisher\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#organization\",\"name\":\"MedicalCRITERIA.com\",\"alternateName\":\"Criterios M\u00e9dicos\",\"url\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/cropped-mc_1024x500.png\",\"contentUrl\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/cropped-mc_1024x500.png\",\"width\":600,\"height\":257,\"caption\":\"MedicalCRITERIA.com\"},\"image\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/medicalcriteria\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#\\\/schema\\\/person\\\/ead6734a2f20659131388ba822c7078c\",\"name\":\"Guillermo Firman\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/24f0f68ba780b5b240680962755c6f75e6116e6667394a46e38b7b8fd0a62e9f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/24f0f68ba780b5b240680962755c6f75e6116e6667394a46e38b7b8fd0a62e9f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/24f0f68ba780b5b240680962755c6f75e6116e6667394a46e38b7b8fd0a62e9f?s=96&d=mm&r=g\",\"caption\":\"Guillermo Firman\"},\"sameAs\":[\"http:\\\/\\\/MedicalCRITERIA.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"[:es]Criterios Diagn\u00f3stico IMWG para Mieloma M\u00faltiple y Trastornos Relacionados de las C\u00e9lulas Plasm\u00e1ticas[:en]IMWG Diagnostic Criteria for Multiple Myeloma and Related Plasma Cell Disorders[:] - MedicalCRITERIA.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/","og_locale":"en_US","og_type":"article","og_title":"[:es]Criterios Diagn\u00f3stico IMWG para Mieloma M\u00faltiple y Trastornos Relacionados de las C\u00e9lulas Plasm\u00e1ticas[:en]IMWG Diagnostic Criteria for Multiple Myeloma and Related Plasma Cell Disorders[:] - MedicalCRITERIA.com","og_description":"Sorry, this entry is only available in Espa\u00f1ol.","og_url":"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/","og_site_name":"MedicalCRITERIA.com","article_publisher":"https:\/\/www.facebook.com\/medicalcriteria\/","article_published_time":"2023-11-17T19:33:13+00:00","article_modified_time":"2025-12-30T19:12:12+00:00","author":"Guillermo Firman","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Guillermo Firman","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/#article","isPartOf":{"@id":"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/"},"author":{"name":"Guillermo Firman","@id":"https:\/\/medicalcriteria.com\/web\/#\/schema\/person\/ead6734a2f20659131388ba822c7078c"},"headline":"IMWG Diagnostic Criteria for Multiple Myeloma and Related Plasma Cell Disorders","datePublished":"2023-11-17T19:33:13+00:00","dateModified":"2025-12-30T19:12:12+00:00","mainEntityOfPage":{"@id":"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/"},"wordCount":1521,"publisher":{"@id":"https:\/\/medicalcriteria.com\/web\/#organization"},"keywords":["Cell","celulas","Criteria","criterios","Diagnostic","diagnostico","Disorders","IMWG","mieloma","Multiple","Myeloma","Plasma","plasmaticas","Related"],"articleSection":["Hematology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/","url":"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/","name":"[:es]Criterios Diagn\u00f3stico IMWG para Mieloma M\u00faltiple y Trastornos Relacionados de las C\u00e9lulas Plasm\u00e1ticas[:en]IMWG Diagnostic Criteria for Multiple Myeloma and Related Plasma Cell Disorders[:] - MedicalCRITERIA.com","isPartOf":{"@id":"https:\/\/medicalcriteria.com\/web\/#website"},"datePublished":"2023-11-17T19:33:13+00:00","dateModified":"2025-12-30T19:12:12+00:00","breadcrumb":{"@id":"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/medicalcriteria.com\/web\/"},{"@type":"ListItem","position":2,"name":"IMWG Diagnostic Criteria for Multiple Myeloma and Related Plasma Cell Disorders"}]},{"@type":"WebSite","@id":"https:\/\/medicalcriteria.com\/web\/#website","url":"https:\/\/medicalcriteria.com\/web\/","name":"MedicalCRITERIA.com","description":"Unifying Concepts","publisher":{"@id":"https:\/\/medicalcriteria.com\/web\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medicalcriteria.com\/web\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/medicalcriteria.com\/web\/#organization","name":"MedicalCRITERIA.com","alternateName":"Criterios M\u00e9dicos","url":"https:\/\/medicalcriteria.com\/web\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medicalcriteria.com\/web\/#\/schema\/logo\/image\/","url":"https:\/\/medicalcriteria.com\/web\/wp-content\/uploads\/2025\/03\/cropped-mc_1024x500.png","contentUrl":"https:\/\/medicalcriteria.com\/web\/wp-content\/uploads\/2025\/03\/cropped-mc_1024x500.png","width":600,"height":257,"caption":"MedicalCRITERIA.com"},"image":{"@id":"https:\/\/medicalcriteria.com\/web\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/medicalcriteria\/"]},{"@type":"Person","@id":"https:\/\/medicalcriteria.com\/web\/#\/schema\/person\/ead6734a2f20659131388ba822c7078c","name":"Guillermo Firman","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/24f0f68ba780b5b240680962755c6f75e6116e6667394a46e38b7b8fd0a62e9f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/24f0f68ba780b5b240680962755c6f75e6116e6667394a46e38b7b8fd0a62e9f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/24f0f68ba780b5b240680962755c6f75e6116e6667394a46e38b7b8fd0a62e9f?s=96&d=mm&r=g","caption":"Guillermo Firman"},"sameAs":["http:\/\/MedicalCRITERIA.com"]}]}},"modified_by":"Guillermo Firman","_links":{"self":[{"href":"https:\/\/medicalcriteria.com\/web\/wp-json\/wp\/v2\/posts\/10205","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicalcriteria.com\/web\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicalcriteria.com\/web\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/wp-json\/wp\/v2\/comments?post=10205"}],"version-history":[{"count":11,"href":"https:\/\/medicalcriteria.com\/web\/wp-json\/wp\/v2\/posts\/10205\/revisions"}],"predecessor-version":[{"id":10222,"href":"https:\/\/medicalcriteria.com\/web\/wp-json\/wp\/v2\/posts\/10205\/revisions\/10222"}],"wp:attachment":[{"href":"https:\/\/medicalcriteria.com\/web\/wp-json\/wp\/v2\/media?parent=10205"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/wp-json\/wp\/v2\/categories?post=10205"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/wp-json\/wp\/v2\/tags?post=10205"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}